Showing results (2351-2360 of 2,573) with videos related to

Sort By:
Pageof 258
Circulation|October 2, 2002
Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study GroupDavid T Balzer, Henry W Kort, Ronald W Day, et al.
Academic Radiology|July 30, 2018
Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in SmokersWassim W Labaki, Tian Gu, Susan Murray, et al.
Plos One|March 28, 2015
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapyCraig J Galbán, Bing Ma, Dariya Malyarenko, et al.
Nature Genetics|November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyColin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Cancer|February 7, 2014
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinibKaren L Reckamp, Giuseppe Giaccone, D Ross Camidge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2024
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung CancerMitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, et al.
Cell Death & Disease|January 26, 2021
Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1Huan-Tian Zhang, Tao Gui, Ri-Xu Liu, et al.
Annals of Internal Medicine|October 24, 1998
Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinomaT Taylor, B Specker, J Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Vascular targeted nanoparticles for imaging and treatment of brain tumorsG Ramachandra Reddy, Mahaveer S Bhojani, Patrick McConville, et al.
The New England Journal of Medicine|June 7, 2017
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung CancerSolange Peters, D Ross Camidge, Alice T Shaw, et al.
Pageof 258